| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2008 | CN101219129A Application of sodium ferulic acid in preparing medicament for expanding vascellum |
| 07/16/2008 | CN101219128A Dexibuprofen pharmaceutical composition with improved dissolving out capability and method for preparing the same |
| 07/16/2008 | CN101219127A Voglibose dispersible tablet, capsule and method for preparing the same |
| 07/16/2008 | CN101219126A Beta-carotene pellet and method for preparing the same |
| 07/16/2008 | CN101219125A Cold water dispersion type xanthophyll micro-capsule and its preparing method |
| 07/16/2008 | CN101219124A Hydrochloric acid cefetamet pivoxil dispersible tablet and method for preparing the same |
| 07/16/2008 | CN101219123A Tea polyphenol pellet and method for preparing the same |
| 07/16/2008 | CN101219122A Hydrochloric acid glitazone dispersion piece and its preparation method |
| 07/16/2008 | CN101219121A Pitavastatin calcium tablet and method for preparing the same |
| 07/16/2008 | CN101219120A Telmisartan dispersible tablet and method for preparing the same |
| 07/16/2008 | CN101219119A Method of preparing simvastatin sustained-release microsphere carried series |
| 07/16/2008 | CN101219117A Cefamandole nafate powder injection, production method of powder injection and raw machine thereof |
| 07/16/2008 | CN101219116A Azithromycin mix suspension grain and method for preparing the same |
| 07/16/2008 | CN101219115A Sustained drug-relase particles and process for producing the same |
| 07/16/2008 | CN101219114A Pennogenin compounds solid state molecule dispersion preparation |
| 07/16/2008 | CN101219113A Compound anticancer sustained-release injection containing bendamustine |
| 07/16/2008 | CN101219112A Compound anticancer sustained-release injection containing bendamustine |
| 07/16/2008 | CN101219111A Anticancer injection containing bendamustine and its potentiating agent |
| 07/16/2008 | CN101219110A Sustained-release injection containing methotrexate potentiating agent |
| 07/16/2008 | CN101219109A Oxolamine sirup and method for producing the same |
| 07/16/2008 | CN101219108A Drug delivery of phase changing formulation |
| 07/16/2008 | CN101219107A Imatinib sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219106A Telatinib sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219105A Emtricitabine sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219104A Cladribine sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219103A Tipifarnib sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219102A Lapatinib sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219101A Fludarabine sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219100A Medicine film for eyes and production method thereof |
| 07/16/2008 | CN100402656C Preparation of highly polyunsaturated fatty acid-containing phosphatidylserine and phosphatidic acid |
| 07/16/2008 | CN100402555C White fungus heteropolysaccharide and its extract, preparation method and uses |
| 07/16/2008 | CN100402549C Bridged bicyclic serine protease inhibitors |
| 07/16/2008 | CN100402546C Steroid compounds with anti-tumor activity |
| 07/16/2008 | CN100402545C Methods and compositions for treating hepatitis c virus |
| 07/16/2008 | CN100402543C Preparation method of hyperin and hypericin of Hypericum perforatum |
| 07/16/2008 | CN100402539C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 07/16/2008 | CN100402534C Tricycle compounds and its application in making medicine |
| 07/16/2008 | CN100402530C Pyrimidotriazines as phosphatase inhibitors |
| 07/16/2008 | CN100402529C Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders |
| 07/16/2008 | CN100402528C Urea substituted imidazopyridines |
| 07/16/2008 | CN100402523C Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
| 07/16/2008 | CN100402521C 4-imidazolin-2-one compounds |
| 07/16/2008 | CN100402517C 9-anthrone lactone compounds, preparing method and use thereof |
| 07/16/2008 | CN100402515C Substituted phthalides as anti-convulsive drugs |
| 07/16/2008 | CN100402510C Oxazole derivatives and their use as insulin sensitizers |
| 07/16/2008 | CN100402506C Ozagrel lysine, preparing method and usage |
| 07/16/2008 | CN100402505C Preparation of allantoin and allantoin extract from cistanche salsa and their use thereof |
| 07/16/2008 | CN100402502C Crystalline form gamma of the chlorhydrate of ivabradine, process for its preparation and phamaceutical composition containing it |
| 07/16/2008 | CN100402501C Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/16/2008 | CN100402497C Fluorinated vitamin D3 analogs |
| 07/16/2008 | CN100402496C Compounds useful as matrix metalloprotease inhibitors |
| 07/16/2008 | CN100402495C Aminoalkylamide substituted cyclohexyl derivatives |
| 07/16/2008 | CN100402494C Myoinositol sulfate aluminium , its preparation method and oral compositions and uses |
| 07/16/2008 | CN100402492C Androgen receptor suppressors in treatment of hirsutism, acne and androgenetic alopecia |
| 07/16/2008 | CN100402483C Process of extracting cimitt acid |
| 07/16/2008 | CN100402088C Method for preparing low molecular weighted glucidamin collagen composition, and its product |
| 07/16/2008 | CN100402087C Lyophilized suspended powder injection and preparation method thereof |
| 07/16/2008 | CN100402080C Medicine composition of refreshing solid dispersion and its preparation and preparing process |
| 07/16/2008 | CN100402064C Liver-protecting sobering-up capsule and method for preparing the same by utilizing grape peel |
| 07/16/2008 | CN100402052C Blood fat-reducing medicine and its preparation method |
| 07/16/2008 | CN100402049C Herpesvirus induced disease medicine and its preparation method |
| 07/16/2008 | CN100402042C Composition and method for augmenting kidney function |
| 07/16/2008 | CN100402041C External application plaster for removing nevus |
| 07/16/2008 | CN100402040C Pain easing pharmaceutical composition and cataplasm thereof |
| 07/16/2008 | CN100402039C Hair growth promoting liquid |
| 07/16/2008 | CN100402038C Use of ginseng saponin C-K in preparing medicine for treating or preventing liver fibrosis |
| 07/16/2008 | CN100402037C Medicine composition for treating valval and/or vaginal diseases |
| 07/16/2008 | CN100402036C Coating agent for treating insomnia and its usage |
| 07/16/2008 | CN100402035C A pharmaceutical composition of microencapsulated cefuroxime axetil |
| 07/16/2008 | CN100402034C Composite amino acid and vitamine capsule preparation and its preparing method |
| 07/16/2008 | CN100402033C Fleroxacin injection and its preparing method |
| 07/16/2008 | CN100402032C Tetrahydroquinoline analogues as muscarinic agonists |
| 07/16/2008 | CN100402031C Parenteral formulations containing a rapamycin hydroxyester |
| 07/16/2008 | CN100402030C Pharmaceutical composition containing amoxicillin and preparation method thereof |
| 07/16/2008 | CN100402029C Combinations comprising epothilone derivatives and alkylating agent |
| 07/16/2008 | CN100402028C Use of abedol in preparation of medicine for preventing and treating hepatitis B, HIV virus |
| 07/16/2008 | CN100402027C Abedol slow release tablet and its preparation method |
| 07/16/2008 | CN100402026C Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 07/16/2008 | CN100402025C Modified release pharmaceutical formulation |
| 07/16/2008 | CN100402024C Gingko lactone freeze dried powder injection and its preparation method |
| 07/16/2008 | CN100402023C Legalon soft capsule and its preparing method |
| 07/16/2008 | CN100402022C Application of erigeron breviscapus and Scutellarin in preparing medication anti tumor |
| 07/16/2008 | CN100402021C Delayed release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol |
| 07/16/2008 | CN100402020C Medicinal formulation in particular for treating herniated invertebral discs |
| 07/16/2008 | CN100402017C Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 07/16/2008 | CN100402015C Cosmetics or medical preparation contg. alkenylaminotriazine as sunlight ageing-proof agent, and alkenylaminotriazine |
| 07/16/2008 | CN100402001C Methods and apparatus for improved administration of fentanyl and supentanil |
| 07/16/2008 | CN100401920C Diet fiber composition with intestine-nourishing constipation-releving functions and its production method |
| 07/16/2008 | CN100401912C Slowly digestable starch product |
| 07/16/2008 | CN100401896C Methods of diagnosis and treatment of interstitial lung disease |
| 07/16/2008 | CN100401887C Antimicrobial envelopes |
| 07/15/2008 | US7399888 Administration of 2-propanone-1,3,5,5-trimethyl-2-cyclohexen-1-ylidine or its isomers, salts or solvates for therapy of epilepsy or seizures |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399867 1-(2-{4-[2-(4-Methanesulfonyl-phenyl)-6-methoxy-3,4-dihydro-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine for therapy of endometriosis and/or uterine leiomyoma/leiomyomata |
| 07/15/2008 | US7399866 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 07/15/2008 | US7399864 Such as 6-(4-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril by reacting carbonstyril compound and tetrazole compound in presence of phase transfer catalyst in water; for producing cilostazol by recrystallization |
| 07/15/2008 | US7399863 e.g. 5-((R)-2-{2-[4-((R)-2-amino-2-phenylethylamino)phenyl]ethylamino}-1-hydroxy-ethyl)-8-hydroxy-1H-quinolin-2-one; premature labor, neurological disorders, cardiac disorders, and inflammation |
| 07/15/2008 | US7399860 Manufacture of polyglutamate-therapeutic agent conjugates |
| 07/15/2008 | US7399856 Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-2pyrimidinyl]amino]benzonitrile |